Diagnosis and treatment of myocardial fibrosis in hypertensive heart disease
Autor(es) : 
Palabras clave : 
Collagen
Fibrosis
Hypertension
Hypertrophy
Fecha de publicación: 
2008
Editorial : 
The Japanese Circulation Society
ISSN: 
1347-4820
Cita: 
Diez J. Diagnosis and treatment of myocardial fibrosis in hypertensive heart disease. Circ J 2008;72 Suppl A:A8-12.
Resumen
Although hypertensive heart disease (HHD) is clinically characterized by development of left ventricular hypertrophy in the absence of a cause other than arterial hypertension, changes in the composition of myocardial tissue also develop in arterial hypertension, leading to structural remodeling of the myocardium (eg, fibrosis). Myocardial fibrosis is the major determinant of diastolic dysfunction/failure in patients with HHD. Recent available data on the determination of serum concentrations of collagen-derived serum peptides, as well as quantitative analysis of echoreflectivity to address the presence of fibrosis in the myocardium of hypertensive patients, are promising. In addition, preliminary data suggest that the goal of reducing myocardial fibrosis is achievable using specific pharmacological agents in patients with HHD.

Ficheros en este registro:
Fichero: 
CircJ200872SuplA812.pdf
Descripción: 
Tamaño: 
345,56 kB
Formato: 
Adobe PDF


Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.